CSI Market
Sign In | Register

Insight Molecular Diagnostics Inc (IMDX) Annual Balance Sheets

Annual · GAAP · USD millions
Access IMDX quarterly Balance Sheets →
Observing balance sheet movements over recent quarters helps explain how Insight Molecular Diagnostics Inc adapts its asset base and funding mix.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent11.58
Cash & Short-term Investments11.00
Accounts receivable1.13
Inventories0.45
Discontinued Operations0.00
Other Current Assets0.00
Prepaid Expense And Other Assets Current1.42
Total Current Assets15.31
Equipment/Property/Plant Net9.25
Goodwill net0.00
Intangible Assets0.00
Tax Assets, Noncurrent0.48
Deferred, Prepaid and Other Assets, Noncurrent0.00
Other Assets, Noncurrent0.00
Equity Securities Fv Ni-
Deposits And Other Noncurrent Assets-
Rightofuse Assets Machinery And Equipment Net-
Total Assets25.76
Liabilities
Accounts Payable, Current AC2.54
Accrued Liabilities, Current AC2.46
Short-term Debt0.00
Other Liabilities, Current0.00
Taxes Payable1.60
Business Combination, Contingent Consideration, Liability, Current BU0.43
Total Current Liabilities12.08
Total Long-term Debt0.00
Accrued Income Taxes, Noncurrent0.48
Other liabilities, Noncurrent0.00
Operating Lease And Financing Lease Liabilities Current-
Operating Lease Liabilities And Financing Lease Liabilities Non Current-
Total Liabilities57.22
Stockholders' Equity
Common Stock Value369.21
Retained Earnings / Accumulated Deficit-400.76
Accumulated Other Comprehensive Income0.09
Other Equity0.09
Common Stockholder's Equity-31.46
Non-controlling interests & other0.00
Total Stockholder's Equity-31.46
Liabilities & Stockholder's Equity25.76
4 historic quarters locked

Sign in to unlock the full Insight Molecular Diagnostics Inc balance sheet history.

Sign In Create Free Account

About Insight Molecular Diagnostics Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001642380-26-000004

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License